OHANNESBURG, 31 August 2007 (PlusNews) - The long road to developing an effective HIV vaccine has been fraught with false leads and disappointing outcomes, but promising preliminary results from a vaccine study conducted in South Africa and the United States suggest scientists may finally be on the right path.
The phase II study was designed to test for evidence that the vaccine could trigger an immune response - the body's natural defence against infection - and also that it would be safe.
The results are sufficiently positive to support future trials investigating whether the vaccine can actually lower the likelihood of contracting HIV or, at the very least, slow the progression of HIV infection to AIDS. read more
No comments:
Post a Comment